Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

31.53
Delayed Data
As of 3:59pm ET
 +1.14 / +3.75%
Today’s Change
11.34
Today|||52-Week Range
39.80
-18.21%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close30.39
Today’s open30.84
Day’s range30.01 - 31.86
Volume22,900
Average volume (3 months)28,110
Market cap$438.2M
Dividend yield2.12%
Data as of 3:59pm ET, 03/26/2015

Growth & Valuation

Earnings growth (last year)-108.57%
Earnings growth (this year)+88.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-81.80%
P/E ratioNM
Price/Sales36.10
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...-0.20-0.83%
XOMAXOMA Corp-0.11-2.97%
SRNESorrento Therapeutic...+0.07+0.59%
NWBONorthwest Biotherape...-0.03-0.41%
Data as of 4:00pm ET, 03/26/2015

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$10.38
Annual revenue (last year)$1.7M
Annual profit (last year)-$27.4M
Net profit margin-1,571.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account